Biomarkers for successful allergen immunotherapy: are we there yet?
PURPOSE OF REVIEW Allergen immunotherapy (AIT) is the only established disease-modifying treatment for IgE-mediated allergic disease, yet treatment remains largely empirical at the individual-patient level. This review critically examines current and emerging biomarkers for successful AIT, distinguishing biomarkers of...